SecBot SecBot
424B5 ·Filed Nov 19, 2026

NIVF

NewGenIvf Group Ltd
BEARISH
Impact 6/10
Horizonimmediate Processed2d 22h ago SEC0001213900-26-122016
Notable filing: 424B5
Actionable Insight ▼ Bearish

Monitor the final prospectus supplement for the actual offering size, price and discount to assess dilution relative to the $2M market cap. The company's Nasdaq listing status remains precarious given the cumulative reverse split ratio and the offering price being below the $1.00 minimum bid price.

DirectionBearish
Confidencemedium
Horizonimmediate

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+1
Entry
$0.0350
T+0 close · Nov 19, 2026 · via day close
Latest settled
−23.14%
T+1 · $0.0269
Vs SPY
−19.50%
α at T+1
Next horizon
T+5
in 5d
  1. T+0 · Nov 19 $0.0350entry
  2. T+1 · 2d ago −23.14%α −19.50% · $0.0269
  3. T+5 · in 5d Pending
  4. T+20 · in 26d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

NewGenIvf Group filed a preliminary prospectus supplement for a firm-commitment underwritten offering of Class A Ordinary Shares and pre-funded warrants, with all key terms (share count, price, discount) left as placeholders. The filing also discloses a Limited Waiver and Repurchase Agreement with noteholder JAK Opportunities VI LLC, requiring a $625,000 repurchase of $584,112 in principal from offering proceeds. The company has a $2M market cap, is under Nasdaq delisting risk, and has executed ten reverse stock splits since February 2025 with a cumulative ratio of approximately 17,280,000-to-1.

Key Financial Metrics

Lock-up
60 days
Underwriters
Aegis Capital Corp.

Key Facts

  • Firm-commitment underwritten offering of Class A Ordinary Shares and pre-funded warrants; all terms (size, price, discount) are placeholder values.
  • 2,993,502 Class A and 9,136 Class B shares outstanding as of November 18, 2026.
  • Last reported sale price on November 18, 2026 was US$0.17 per share.
  • Underwriter is Aegis Capital Corp.; underwriting discount is 9.0% of gross proceeds.
  • Mandatory repurchase of $584,112 principal of the JAK Exchange Note for $625,000 from offering proceeds.
  • Company has been under Nasdaq delisting notice since November 2024; ten reverse stock splits with cumulative ratio of ~17,280,000-to-1 since February 2025.
  • Another 1-for-100 reverse stock split approved with tentative effective date of December 1, 2026.
  • Revenue for six months ended June 30, 2026 was $1,924,881, down from $2,019,628 in the prior-year period.
  • Net loss for six months ended June 30, 2026 was $(8,079,392) vs net income of $698,032 in the prior-year period.
  • Market cap is $2M; normal daily move is 34.7%.

Financial Impact

Offering size, price and discount are undisclosed; $625,000 of gross proceeds committed to repurchase $584,112 of the JAK Exchange Note.

dilutiondebt reduction

Risk Factors

  • All offering terms are placeholders; the final terms could be highly dilutive given the $2M market cap.
  • Nasdaq delisting risk is elevated: the offering price is below $1.00, and the cumulative reverse split ratio of 17,280,000-to-1 eliminates the ordinary bid-price compliance period.
  • Revenue declined 4.7% YoY and the company swung to a $8.1M net loss for the six months ended June 30, 2026.
  • document contains text addressed to automated readers

Market Snapshot

Exchange
Nasdaq
Sector
Services-Misc Health & Allied Services, NEC

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0001213900-26-122016
Document: 0001213900-26-122016-index-headers.html0001213900-26-122016
Document: 0001213900-26-122016-index.html0001213900-26-122016
Document: 0001213900-26-122016.txt0001213900-26-122016

Track record

27 reports on NIVF

Performance horizon

10 of 12 bullish or bearish reports moved the stock their way by T+20. Best: +99.57% at T+60 after the Aug 20, 2026 report. 13 of 13 went positive at some point.

Filters
  1. Nov 20, 20261d ago 424B5 Bearish 7/10 Entry $0.0318 Now $0.0270 +15.09% settles Dec 21
  2. Nov 19, 20262d ago 424B5 Bearish 6/10 Viewing Entry $0.0350 Now $0.0270 +22.86% settles Dec 18
  3. Nov 17, 20264d ago 6-K Neutral 2/10 Entry $0.1728 Now $0.0270 −84.37% settles Dec 16
  4. Nov 16, 20265d ago 6-K Neutral 3/10 Entry $0.2050 Now $0.0270 −86.83% settles Dec 15
  5. Nov 13, 20269d ago EFFECT Bearish 5/10 Entry $0.2312 Now $0.0270 +88.32% settles Dec 14
  6. Oct 21, 20264w ago 6-K Neutral 4/10 Entry $0.1884 Now $0.0270 −85.67% due Nov 18
  7. Oct 7, 20266w ago 6-K Bearish 7/10 Entry $0.0811 to $0.0152 Now $0.0270 +66.71% ▲ +81.23% +75.94% vs SPY
  8. Oct 7, 20266w ago 6-K Neutral 3/10 Entry $0.1060 to $0.0216 Now $0.0270 −74.53% ▼ −79.58% −78.24% vs SPY
  9. Oct 6, 20266w ago SC 13D/A Neutral 3/10 Entry $0.0987 to $0.0266 Now $0.0270 −72.64% ▼ −73.09% −69.91% vs SPY
  10. Oct 5, 20266w ago 6-K Bearish 6/10 Entry $0.1100 to $0.0306 Now $0.0270 +75.45% ▲ +72.16% +69.70% vs SPY
Showing 10 of 27

US Market Status

Market Closed · Opens Mon (26h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 19, 2026